# Court Decisions, ANDA Approvals, and 180-Day Exclusivity Under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance/court-decisions-anda-approvals-and-180-day-exclusivity-under-the-hatch-waxman-amendments-to-the-federal-food-drug-and-cosmetic-act/4d91b564-120c-4376-be51-25fecf8aa7a3

> FDA guidance document: Court Decisions, ANDA Approvals, and 180-Day Exclusivity Under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act. Issue date: March 27, 2000. Get complete insights and analysis.

---

## Details

- Title: Court Decisions, ANDA Approvals, and 180-Day Exclusivity Under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act
- Product Type: other
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2000-03-27
- Last Changed: 2018-12-01

## Related Documents

- [Implementation of Section 120 of the Food and Drug Administration Modernization Act of 1997-Advisory Committees](https://www.globalkeysolutions.net/guidances/guidance-document/implementation-of-section-120-of-the-food-and-drug-administration-modernization-act-of-1997-advisory-committees/45b9b815-ce9c-4261-b77c-20e27647c07e)
- [Standards for the Prompt Review of Efficacy Supplements, Including Priority Efficacy Supplements :  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/standards-for-the-prompt-review-of-efficacy-supplements-including-priority-efficacy-supplements-guidance-for-industry/b8c315e8-9952-4fdf-8200-d0e668dfb47d)
- [180-Day Generic Drug Exclusivity Under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act](https://www.globalkeysolutions.net/guidances/guidance-document/180-day-generic-drug-exclusivity-under-the-hatch-waxman-amendments-to-the-federal-food-drug-and-cosmetic-act/99b50bce-632e-41dc-871f-60d4142d9386)